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Alongside the major interest for Parkinson’s disease (PD)
motor symptoms, in recent years, there has been increasing
attention to PD-associated nonmotor symptoms. Behavioral
and emotional dysfunctions have been identiﬁed as major
determinants of health-related quality-of-life impairment,
frequently aﬀecting PD patients since the very ﬁrst stages of
the disease or even before the onset of classical motor
symptoms [1, 2, 3]. Despite their major impact on the quality
of life, behavioral and emotional disorders may be under-
recognized and untreated in PD.
Although the exact pathogenesis of behavioral and
emotional disorders associated with PD remains to be clar-
iﬁed, several mechanisms have been identiﬁed. Because of the
complex role of basal ganglia in processing a wide range of
motor and nonmotor information [4, 5], dysfunction in these
structures is thought to play a key role in generating be-
havioral and emotional disorders in PD. Other mechanisms,
however, include dopaminergic and nondopaminergic dys-
functions of several pathways at the subcortical and cortical
levels, including the limbic system [6, 7].
It is worth considering that PD aﬀects over 6 million
people worldwide and that this number is projected to
double by 2040 [8]. "e need for expanding the knowledge
on behavioral and emotional dysfunctions represents,
therefore, a key priority for clinicians and researchers and is
crucial to the eﬀective treatment of these disturbances.
"is special issue was speciﬁcally designed to focus on
three main critical areas, namely, (a) evidence of PD-
associated behavioral and emotional dysfunctions, (b)
neural correlates and pathophysiological aspects of behav-
ioral and emotional dysfunction associated with PD, and (c)
clinimetric assessment and screening instruments for PD-
associated behavioral and emotional dysfunctions.
From the initial analysis of thirteen papers submitted by
international researchers, seven were identiﬁed as the most
relevant and peer-reviewed by experts in the ﬁeld. "e
following is a short summary of the major ﬁndings of each of
these papers.
Imaging genetics is a novel-integrated research method
which combines diﬀerent techniques in the attempt to dis-
entangle the relationship between genetic factors and brain
functions or structures. By using this experimental approach,
Y. Zhi et al. further investigated the pathophysiological basis
of depression in patients. "e authors employed resting-state
functional magnetic resonance imaging and tested the do-
pamine receptor D3 gene polymorphism."ey found that the
D3 gene Ser9Gly polymorphism was associated with more
severe anhedonia in PD patients. "ey discussed the possible
role of the frontal areas, namely, the right inferior occipital
gyrus, lingual gyrus, and fusiform gyrus, in generating de-
pressive symptoms in PD. "e association between genetic
variants imaging phenotypes and diﬀerent clinical manifes-
tations of nonmotor symptoms should be further explored in
future studies.
Hallucinations are common disturbances in patients
with PD. Previous studies have mainly investigated the
neural correlates of well-formed visual hallucinations in PD
patients with advanced disease. By contrast, less is known
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about patients in the early stages of the disease and about
minor hallucinations. C. M. Sawczak et al. investigated the
contribution of the attention networks in generating minor
hallucinations in PD. In their neuroimaging study, the
authors demonstrated a thicker cortex in both the dorsal and
ventral attention networks. It is noteworthy to remark,
however, that prior work showed the opposite result,
i.e., grey matter reductions in PD. "erefore, the available
data so far indicate a variable pattern of cortical thickness
alterations associated with hallucinations in PD. Further
investigations and longitudinal studies are warranted to
better deﬁne the neural correlates of PD psychosis.
Even though the decline in motor performance is the
most prominent feature of PD progression, the relationship
betweenmovement abnormalities and nonmotor symptoms,
including a deﬁcit in motivation, is far from being un-
derstood. In their original study, M. Kojovic et al. tested the
eﬀect of monetary incentive on movement speed in PD
patients treated with STN-DBS and dopaminergic medi-
cations."e results indicate that motivational modulation of
movement speed may be enhanced as a direct consequence
of DBS rather than dopaminergic treatment."e results may
be relevant for future and innovative rehabilitation
programs.
In their viewpoint paper entitled “Motor and nonmotor
symptoms of PD; antagonistic pleiotropy phenomena de-
rived from α-synuclein evolvability?,” Y. Takamatsu et al.
discuss nonmotor symptoms, including depression and
anxiety, in PD and other synucleinopathies in an evolu-
tionary perspective. "e authors also discuss possible im-
plications related to novel therapeutic strategies.
Mounting shreds of evidence suggest that people with
PD perform poorly on tests assessing the ability to infer the
beliefs, desires, and intentions of others. All these functions
fall under the umbrella term of “"eory of Mind” (ToM). In
their original paper, J. A. Foley et al. reveal that apparent
impairment observed on ToM tests in PD patients is
explained by altered executive functions. Among these, the
authors report deﬁcits in inhibition, likely due to neuro-
pathological, metabolism, or connectivity changes of the
frontal lobe in PD. "e results highlight the importance of
accurate neuropsychological testing in PD patients.
Proper assessment of behavioral and emotional dys-
functions in PD is a challenging issue, in both clinical and
research contexts. For these purposes, various scales exist;
however, their reliability and validity are not always tested in
speciﬁc populations where contextual, social, and envi-
ronmental factors may signiﬁcantly inﬂuence the outcome
measure. "us, psychometric properties of the clinical scales
have been often studied in diﬀerent pathologies and in
diﬀerent settings. P. Massai et al. investigated the internal
consistency, test-retest reliability, and construct and dis-
criminant validity of the Geriatric Depression Scale (GDS) in
Italian people with PD. "eir results demonstrate that GDS
is reliable and valid in Italian patients to quantify depression
in PD.
With an estimated prevalence of ∼3–42%, impulse
control behaviours (ICB) and disorders (ICD) represent one
of themost signiﬁcant nonmotor health problems in patients
with PD. Questionnaire for Impulsive-Compulsive Disor-
ders in PD (QUIP) is the most commonly used screening
instrument for ICD in PD patients. E. Mare´chal et al.
translated the QUIP into Flemish to develop a useful
screening instrument for ICD in the Belgian population.
"ey used a translation-backtranslation method. "e results
of this pilot study suggest that the validity of the ques-
tionnaire is similar to the original version. "e authors
emphasize the role of a proper screening instrument for the
detection of ICB and ICD in the people with PD.
We believe that this special issue will contribute to raise
interest in several aspects related to behavioral and emo-
tional dysfunction in PD. We aimed to highlight original
research ﬁndings from a broad perspective. We hope that
this special issue might inspire future and novel research
approaches to tackle some of the unsolved, and still con-
troversial, issues highlighted in the various studies.
In conclusion, we would like to thank all the authors, the
reviewers, and the editorial board members for their eﬀort in
constructing this special issue on behavioral and emotional
dysfunction in PD.
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